{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:26:27Z","timestamp":1785252387623,"version":"3.55.0"},"update-to":[{"DOI":"10.1002\/14651858.cd006919.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000}}],"reference-count":153,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd006919.pub5","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T06:52:35Z","timestamp":1736405555000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Gonadotropin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction"],"prefix":"10.1002","volume":"2025","author":[{"given":"Charalampos S","family":"Siristatidis","sequence":"additional","affiliation":[{"name":"Assisted Reproduction Unit, Second Department of Obstetrics and Gynaecology, Aretaieion Hospital; Medical School, National and Kapodistrian University of Athens; Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li Ning","family":"Yong","sequence":"additional","affiliation":[{"name":"Department of Obstetrics & Gynaecology; University of Auckland; Auckland New Zealand"},{"name":"University of Auckland; Auckland New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abha","family":"Maheshwari","sequence":"additional","affiliation":[{"name":"Aberdeen Fertility Centre; NHS Grampian; Aberdeen UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smriti","family":"Ray Chaudhuri Bhatta","sequence":"additional","affiliation":[{"name":"Institute of Education in Healthcare and Medical Sciences; University of Aberdeen; Aberdeen UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,1,9]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD006919.pub5-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0015-0282(16)54964-4","article-title":"Prospective study of short and long regimens of gonadotropin-releasing hormone agonist in in vitro fertilization program","volume":"57","author":"Acharya","year":"1992","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD006919.pub5-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"147","DOI":"10.15296\/ijwhr.2020.23","article-title":"A comparison of three different controlled ovarian stimulation protocols in poor women responders chosen according to POSEIDON criteria: micro-dose, standard flare-up, and antagonist protocol","volume":"8","author":"Al-Jeborry","year":"2020","journal-title":"International Journal of Women's Health and Reproductive Sciences"},{"issue":"4","key":"10.1002\/14651858.CD006919.pub5-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.5152\/jtgga.2010.35","article-title":"Comparison of the ultrashort gonadotropin-releasing hormone agonist-antagonist protocol with microdose flare-up protocol in poor responders: a preliminary study","volume":"11","author":"Berker","year":"2010","journal-title":"Journal of the Turkish German Gynecological Association"},{"issue":"5","key":"10.1002\/14651858.CD006919.pub5-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/humrep\/15.5.1009","article-title":"Consequences on gonadotrophin secretion of an early discontinuation of gonadotrophin-releasing hormone agonist administration in short term protocol for in vitro fertilization","volume":"15","author":"Cedrin-Durnerin","year":"2000","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"11","key":"10.1002\/14651858.CD006919.pub5-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.gyobfe.2011.08.025","article-title":"Prospective randomised study of long versus short agonist protocol with poor responder patients during in vitro fertilization","volume":"40","author":"Chatillon-Boissier","year":"2012","journal-title":"Gyn\u00e9cologie Obst\u00e9trique & Fertilit\u00e9"},{"key":"10.1002\/14651858.CD006919.pub5-BIB0006|cit6","first-page":"9","article-title":"Comparison of long-term versus three-day leuprolide acetate for ovarian stimulation in human in vitro fertilization program","volume":"1","author":"Chen","year":"1992","journal-title":"Journal of Reproduction and Fertility"},{"issue":"7","key":"10.1002\/14651858.CD006919.pub5-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1093\/humrep\/16.7.1409","article-title":"Effect of reduced dose of triptorelin at the start of ovarian stimulation on the outcome of IVF: a randomized study","volume":"16","author":"Dal Prato","year":"2001","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD006919.pub5-BIB0008|cit8","first-page":"339","article-title":"Long acting versus daily administration GnRH analogs in IVF (abstract)","volume":"6","author":"De Placido","year":"1991","journal-title":"Human Reproduction"},{"issue":"2","key":"10.1002\/14651858.CD006919.pub5-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.rbmo.2013.04.014","article-title":"Withdrawal of GnRH agonist decreases oestradiol and VEGF concentrations in high responders","volume":"27","author":"Ding","year":"2013","journal-title":"Reproductive BioMedicine Online"},{"issue":"6","key":"10.1002\/14651858.CD006919.pub5-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/BF01133025","article-title":"A randomized prospective study on the effect of short and long buserelin treatment in women with repeated unsuccessful in vitro fertilization (IVF) cycles due to inadequate ovarian response","volume":"8","author":"Dirnfeld","year":"1991","journal-title":"Journal of in Vitro Fertilization and Embryo Transfer"},{"issue":"3","key":"10.1002\/14651858.CD006919.pub5-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0015-0282(99)00289-7","article-title":"Cessation of gonadotropin-releasing hormone analogue (GnRH-a) upon down-regulation versus conventional long GnRH-a protocol in poor responders undergoing in vitro fertilization","volume":"72","author":"Dirnfeld","year":"1999","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD006919.pub5-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.fertnstert.2004.10.032","article-title":"Effect of halving the daily dose of triptorelin at the start of ovarian stimulation on hormone serum levels and the outcome of in vitro fertilization","volume":"83","author":"F\u00e1bregues","year":"2005","journal-title":"Fertility and Sterility"},{"issue":"15","key":"10.1002\/14651858.CD006919.pub5-BIB0013|cit13","first-page":"719","article-title":"Systematic inhibition of the luteinizing hormone with a gonadoliberin analog, triptorelin, during ovarian stimulation for fertilization in vitro: choice of protocol","volume":"17","author":"Fenichel","year":"1988","journal-title":"Presse M\u00e9dicale"},{"key":"10.1002\/14651858.CD006919.pub5-BIB0014|cit14","first-page":"628","article-title":"Randomized study comparing the short and long protocols of buserelin in 100 in vitro fertilization cycles","volume":"16","author":"Foulot","year":"1988","journal-title":"Contraception, Fertilite, Sexualite"},{"issue":"3","key":"10.1002\/14651858.CD006919.pub5-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0015-0282(16)60135-8","article-title":"Comparison between flare up and down regulation effects of luteinizing hormone-releasing hormone agonists in an in vitro fertilization program","volume":"50","author":"Frydman","year":"1988","journal-title":"Fertility and Sterility"},{"issue":"11","key":"10.1002\/14651858.CD006919.pub5-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1093\/humrep\/15.11.2292","article-title":"High doses of gonadotrophins combined with stop versus non-stop protocol of GnRH analogue administration in low responder IVF patients: a prospective, randomized controlled trial","volume":"15","author":"Garcia-Velasco","year":"2000","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD006919.pub5-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/ijgo.12988","article-title":"Randomized controlled trial of gonadotropin-releasing hormone agonist microdose flare-up versus flare-up among poor responders undergoing intracytoplasmic sperm injection","volume":"148","author":"Ghaffari","year":"2020","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"3","key":"10.1002\/14651858.CD006919.pub5-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0015-0282(16)55806-3","article-title":"Comparison of short 7 day and prolonged treatment with gonadotropin-releasing hormone agonist desensitization for controlled ovarian hyperstimulation","volume":"59","author":"Hazout","year":"1993","journal-title":"Ferility and Sterility"},{"key":"10.1002\/14651858.CD006919.pub5-BIB0019|cit19","first-page":"624","article-title":"Randomized comparison of the long and short protocols for ovarian stimulation in association with GnRH agonist for in vitro fertilization","volume":"16","author":"Hedon","year":"1988","journal-title":"Contraception, Fertilite, Sexualite"},{"issue":"7","key":"10.1002\/14651858.CD006919.pub5-BIB0020|cit20","first-page":"639","article-title":"Extension of GnRH agonist through the luteal phase to improve the outcome of intracytoplasmic sperm injection","volume":"52","author":"Isikoglu","year":"2007","journal-title":"Journal of Reproductive Medicine"},{"issue":"4","key":"10.1002\/14651858.CD006919.pub5-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0015-0282(16)54962-0","article-title":"The routine use of gonadotropin-releasing hormone agonists for all patients undergoing in vitro fertilization. Is there any medical advantage? A prospective randomized study","volume":"57","author":"Kingsland","year":"1992","journal-title":"Fertility and Sterility"},{"issue":"4","key":"10.1002\/14651858.CD006919.pub5-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0015-0282(16)58571-9","article-title":"A randomized prospective study of early follicular or midluteal initiation of long protocol gonadotropin-releasing hormone in an in vitro fertilization program","volume":"66","author":"Kondaveeti-Gordon","year":"1996","journal-title":"Fertility and Sterility"},{"issue":"9","key":"10.1002\/14651858.CD006919.pub5-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"846","DOI":"10.3109\/09513590.2013.813475","article-title":"Effect of delayed initiation of gonadotropin in luteal long protocol on in vitro fertilization","volume":"29","author":"Lin","year":"2013","journal-title":"Gynecological Endocrinology"},{"issue":"1","key":"10.1002\/14651858.CD006919.pub5-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0015-0282(16)60437-5","article-title":"Hormonal changes induced by short-term administration of gonadotropin-releasing hormone agonist during ovarian hyperstimulation for in vitro fertilization and their consequences for embryo development","volume":"51","author":"Loumaye","year":"1989","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD006919.pub5-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/oxfordjournals.humrep.a136889","article-title":"Ovarian response and outcome of in-vitro fertilization in patients treated with gonadotrophin-releasing hormone analogues in different phases of menstrual cycle","volume":"4","author":"Pellicer","year":"1989","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"2","key":"10.1002\/14651858.CD006919.pub5-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0015-0282(16)53695-4","article-title":"The comparison of early follicular and midluteal administration of long acting gonadotropin-releasing hormone agonist","volume":"54","author":"Ron-El","year":"1990","journal-title":"Fertility and Sterility"},{"issue":"4","key":"10.1002\/14651858.CD006919.pub5-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0015-0282(16)55322-9","article-title":"A prospective randomized comparison of luteal phase versus concurrent follicular phase initiation of gonadotropin-releasing hormone agonist for in-vitro fertilization","volume":"58","author":"San Roman","year":"1992","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD006919.pub5-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"S472","DOI":"10.1016\/j.fertnstert.2013.07.451","article-title":"Comparing stimulation requirements and final outcome between early follicular and mid luteal-starting of pituitary suppression in the long gonadotropin releasing hormone agonist protocol","volume":"100 Suppl (2)","author":"Sarhan","year":"2013","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD006919.pub5-BIB0029|cit29","doi-asserted-by":"publisher","first-page":"72","DOI":"10.5935\/1518-0557","article-title":"Hormonal responses and clinical outcome are the same with three doses of gonadotropin-releasing hormone agonist used in the short stimulation protocol","volume":"20","author":"Sarhan","year":"2016","journal-title":"JBRA Assisted Reproduction"},{"issue":"10","key":"10.1002\/14651858.CD006919.pub5-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1093\/oxfordjournals.humrep.a138340","article-title":"A comparison between a standard and reduced dose of D-Trp-6-luteinizing hormone-releasing hormone administered after pituitary suppression for in-vitro fertilization","volume":"9","author":"Simon","year":"1994","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"4","key":"10.1002\/14651858.CD006919.pub5-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.fertnstert.2004.10.044","article-title":"Early cessation of triptorelin in in vitro fertilization: a double blind, randomized study","volume":"83","author":"Simons","year":"2005","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD006919.pub5-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.fertnstert.2013.09.035","article-title":"Long gonadotropin-releasing hormone agonist versus short agonist versus antagonist regimens in poor responders undergoing in vitro fertilization: a randomized controlled trial","volume":"101","author":"Sunkara","year":"2014","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD006919.pub5-BIB0033|cit33","doi-asserted-by":"crossref","unstructured":"Sunkara SK Coomarasamy A Khalaf Y Braude P A three-arm randomised controlled trial comparing gonadotrophin releasing hormone (GnRH) agonist long regimen versus GnRH agonist short regimen versus GnRH antagonist regimen in women with a history of poor ovarian response undergoing in vitro fertilisation (IVF) treatment: Poor Responders INtervention Trial (PRINT) Reproductive Health 2007 4 12 18163902","DOI":"10.1186\/1742-4755-4-12"},{"key":"10.1002\/14651858.CD006919.pub5-BIB0034|cit34","first-page":"311","article-title":"Effectiveness of the GnRH agonist long, GnRH agonist short and GnRH antagonist regimens in poor responders undergoing IVF treatment: a three arm randomised controlled trial","volume":"28","author":"Sunkara","year":"2013","journal-title":"Human Reproduction"},{"issue":"4","key":"10.1002\/14651858.CD006919.pub5-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0015-0282(16)54963-2","article-title":"The long protocol of administration of gonadotropin-releasing hormone agonist is superior to the short protocol for ovarian stimulation for in-vitro fertilization","volume":"57","author":"Tan","year":"1992","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD006919.pub5-BIB0036|cit36","first-page":"25","article-title":"Is long-protocol gonadotropin releasing hormone agonist administration superior to the short protocol in ovarian stimulation for in-vitro fertilization?","volume":"40","author":"Tasdemir","year":"1995","journal-title":"International Journal of Fertility and Menopausal Studies"},{"issue":"5","key":"10.1002\/14651858.CD006919.pub5-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0015-0282(16)58270-3","article-title":"Midluteal buserelin is superior to early follicular phase buserelin in combined gonadotropin-releasing hormone analog and gonadotropin stimulation in in vitro fertilization","volume":"65","author":"Urbancsek","year":"1996","journal-title":"Fertility and Sterility"},{"issue":"6","key":"10.1002\/14651858.CD006919.pub5-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/BF01130591","article-title":"Comparison of ovarian stimulation regimens for in vitro fertilization (IVE) with and without a gonadotropin-releasing hormone (GnRH) agonist: results of a randomized study","volume":"7","author":"Van de-Helder","year":"1990","journal-title":"Journal of In Vitro Fertilization and Embryo Transfer"},{"issue":"4","key":"10.1002\/14651858.CD006919.pub5-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0015-0282(02)04928-2","article-title":"Prospective evaluation of two stimulation protocols for low responders who were undergoing in vitro fertilization-embryo transfer","volume":"79","author":"Weissman","year":"2003","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD006919.pub5-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1447-0756.1996.tb00955.x","article-title":"The evaluation of a new 7-day gonadotropin-releasing hormone agonist protocol in the controlled ovarian hyperstimulation for in vitro fertilization","volume":"22","author":"Yang","year":"1996","journal-title":"Journal of Obstetrics and Gynaecology Research"},{"issue":"4","key":"10.1002\/14651858.CD006919.pub5-BIB0041|cit41","first-page":"222","article-title":"A prospective, randomized controlled study comparing the effects of gonadotropin-releasing hormone agonist long and short protocols for in vitro fertilization","volume":"36","author":"Ye","year":"2001","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"issue":"3","key":"10.1002\/14651858.CD006919.pub5-BIB0042|cit42","first-page":"190","article-title":"Effect of 7-day gonadotropin-releasing hormone agonist protocol on IGF-II and IGFBP-4 levels in the follicular fluid","volume":"34","author":"Zhang","year":"2009","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"issue":"4","key":"10.1002\/14651858.CD006919.pub5-BIB0043|cit43","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.ajme.2012.04.001","article-title":"Effect of aromatase inhibitor (letrozole) with long agonist protocol on the results of ICSI\/ET in females with minimal and mild endometriosis","volume":"48","author":"Abd Rabbo","year":"2012","journal-title":"Alexandria Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD006919.pub5-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00404-012-2337-z","article-title":"Efficacy of low-dose hCG in late follicular phase in controlled ovarian stimulation using GnRH agonist protocol","volume":"286","author":"Aflatoonian","year":"2012","journal-title":"Archives of Gynecology and Obstetrics"},{"issue":"1","key":"10.1002\/14651858.CD006919.pub5-BIB0045|cit45","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002808.pub3","article-title":"Depot versus daily administration of gonadotrophin-releasing hormone agonist protocols for pituitary down regulation in assisted reproduction cycles","author":"Albuquerque","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD006919.pub5-BIB0046|cit46","first-page":"1035","article-title":"Ovarian stimulation for in vitro fertilization using LHRH agonists: comparison of plasma and intra-follicular hormone profiles using \"short\" and \"long\" protocols","volume":"19","author":"Antoine","year":"1990","journal-title":"Journal de Gynecologie, Obstetrique et Biologie de la Reproduction"},{"issue":"4","key":"10.1002\/14651858.CD006919.pub5-BIB0047|cit47","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1016\/j.fertnstert.2022.08.181","article-title":"A three-dose- GnRH agonist triggering protocol to improve live births in hyper-responders undergoing fresh embryo transfer and intensive luteal support: a prospective randomised controlled clinical trial","volume":"118","author":"Awwad","year":"2022","journal-title":"Fertility and Sterility"},{"issue":"4 Suppl","key":"10.1002\/14651858.CD006919.pub5-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"S163","DOI":"10.1016\/j.fertnstert.2010.07.649","article-title":"Comparison of short and long GnRH agonist protocols using recombinant FSH for IVF\/ICSI: a controlled prospective study","volume":"94","author":"Azem","year":"2010","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD006919.pub5-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/humrep\/15.1.43","article-title":"Follicular and luteal phase characteristics following early cessation of gonadotrophin-releasing hormone agonist during ovarian stimulation for in-vitro fertilization","volume":"15","author":"Beckers","year":"2000","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"1","key":"10.1002\/14651858.CD006919.pub5-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.fertnstert.2010.07.1073","article-title":"GnRH-agonist induced depressive and anxiety symptoms during in vitro fertilization-embryo transfer cycles","volume":"95","author":"Bloch","year":"2011","journal-title":"Fertility and Sterility"},{"issue":"8 Suppl","key":"10.1002\/14651858.CD006919.pub5-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/humrep\/4.suppl_1.121","article-title":"Endocrine profiles and luteal function during GnRH-analogue\/HMG therapy","volume":"4","author":"Braendle","year":"1989","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD006919.pub5-BIB0052|cit52","first-page":"436","article-title":"Requiem for the short protocol?","volume":"21","author":"Buvat","year":"1993","journal-title":"Contraception, Fertilite, Sexualite"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD006919.pub5-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"S175","DOI":"10.1016\/j.fertnstert.2011.07.683","article-title":"Triptorelin every other day can prevent premature LH surge: a strategy to reduce the daily gonadotrophin-releasing hormone agonists injections","volume":"96","author":"Cambiaghi","year":"2011","journal-title":"Fertility and Sterility"},{"issue":"16","key":"10.1002\/14651858.CD006919.pub5-BIB0054|cit54","first-page":"[12 p.]","article-title":"The effectiveness of different down-regulating protocols on in vitro fertilization-embryo transfer in endometriosis: a meta-analysis","volume":"18","author":"Cao","year":"2020","journal-title":"Reproductive Biology and Endocrinology : RB&E"},{"issue":"1","key":"10.1002\/14651858.CD006919.pub5-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/oxfordjournals.humrep.a137551","article-title":"Comparison of short versus long-term leuprolide acetate-human menopausal gonadotrophin hyperstimulation in in-vitro fertilization patients","volume":"7","author":"Check","year":"1992","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD006919.pub5-BIB0056|cit56","doi-asserted-by":"publisher","first-page":"9424","DOI":"10.12659\/MSM.913757","article-title":"Comparative effectiveness of three ovarian hyperstimulation protocol in in vitro fertilization (IVF) cycles for women with polycystic ovary syndrome","volume":"24","author":"Chen","year":"2018","journal-title":"Medical Science Monitor"},{"issue":"4","key":"10.1002\/14651858.CD006919.pub5-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"662","DOI":"10.3346\/jkms.2008.23.4.662","article-title":"Comparison of clinical efficacy between a single administration of long-acting gonadotrophin-releasing hormone agonist (GnRHa) and daily administrations of short-acting GnRHa in in vitro fertilization-embryo transfer cycles","volume":"23","author":"Cheon","year":"2008","journal-title":"Journal of Korean Medical Science"},{"key":"10.1002\/14651858.CD006919.pub5-BIB0058|cit58","unstructured":"A comparative of triptorelin and buserelin in the outcome of IVF https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=IRCT20210529051424N1"},{"issue":"3","key":"10.1002\/14651858.CD006919.pub5-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0015-0282(16)54907-3","article-title":"Leuprolide acetate-prepared in vitro fertilization-gamete intrafallopian transfer cycles: efficacy versus controls and cost analysis","volume":"57","author":"Corson","year":"1992","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD006919.pub5-BIB0060|cit60","doi-asserted-by":"publisher","first-page":"116","DOI":"10.3109\/09513590.2015.1092136","article-title":"Which is the best IVF\/ICSI protocol to be used in poor responders receiving growth hormone as an adjuvant treatment? A prospective randomized trial","volume":"32","author":"Dakhly","year":"2016","journal-title":"Gynecological Endocrinology"},{"issue":"1","key":"10.1002\/14651858.CD006919.pub5-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejogrb.2011.06.030","article-title":"Prolonging GnRH-agonist to achieve ovarian suppression does not compromise the results of a long protocol","volume":"159","author":"Dessolle","year":"2011","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"issue":"6","key":"10.1002\/14651858.CD006919.pub5-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1093\/oxfordjournals.humrep.a138634","article-title":"Clinical outcome of a pilot efficacy study on recombinant human follicle-stimulating hormone (Org 32489) combined with various gonadotrophin-releasing hormone agonist regimens","volume":"9","author":"Devroey","year":"1994","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"2","key":"10.1002\/14651858.CD006919.pub5-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0015-0282(16)54847-X","article-title":"The effect of gonadotropin-releasing hormone agonist on the ovarian response and in vitro fertilization results in polycystic ovarian syndrome: a prospective study","volume":"57","author":"Dor","year":"1992","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD006919.pub5-BIB0064|cit64","first-page":"133","article-title":"Comparison of pregnancy outcome in half-dose Triptorelin and short-acting Decapeptyl in long protocol in ART cycles: a randomized clinical trial","volume":"11","author":"Eftekhar","year":"2013","journal-title":"Iranian Journal of Reproductive Medicine"},{"issue":"9","key":"10.1002\/14651858.CD006919.pub5-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1093\/humrep\/13.9.2382","article-title":"Reducing the dose of gonadotrophin-releasing hormone agonist on starting ovarian stimulation: effect on ovarian response and in-vitro fertilization outcome","volume":"13","author":"Elgendy","year":"1998","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"5","key":"10.1002\/14651858.CD006919.pub5-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0015-0282(98)00040-5","article-title":"Cessation of gonadotropin-releasing hormone agonist therapy combined with high-dose gonadotropin stimulation yields favourable pregnancy results in low responders","volume":"69","author":"Faber","year":"1998","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD006919.pub5-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0015-0282(16)58037-6","article-title":"Relationship of timing of agonist administration in the cycle phase to the ovarian response to gonadotropins in the long down-regulation protocols for assisted reproductive technologies","volume":"65","author":"Ferraretti","year":"1996","journal-title":"Fertility and Sterility"},{"issue":"6","key":"10.1002\/14651858.CD006919.pub5-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/S0015-0282(97)81458-6","article-title":"A prospective randomized comparison between long and discontinuous-long protocols of gonadotropin-releasing hormone agonist for in vitro fertilization","volume":"67","author":"Fujii","year":"1997","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD006919.pub5-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0015-0282(16)53285-3","article-title":"Follicular phase gonadotropin-releasing hormone agonist and human gonadotropins: a better alternative for ovulation induction in in vitro fertilization","volume":"53","author":"Garcia","year":"1990","journal-title":"Fertility and Sterility"},{"issue":"9","key":"10.1002\/14651858.CD006919.pub5-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1093\/oxfordjournals.humrep.a138758","article-title":"The effects of gonadotrophin-releasing hormone agonist on follicular development in patients with polycystic ovary syndrome in an in-vitro fertilization and embryo transfer programme","volume":"9","author":"Gersak","year":"1994","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"2","key":"10.1002\/14651858.CD006919.pub5-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/oxfordjournals.humrep.a138485","article-title":"Prospective randomized study of D-Trp6-LHRH versus buserelin in long desensitization protocols for medically assisted conception cycles","volume":"9","author":"Gianaroli","year":"1994","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD006919.pub5-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/09513590.2014.964638","article-title":"Which luteal phase support is better for each IVF stimulation protocol to achieve the highest pregnancy rate? A superiority randomized clinical trial","volume":"30","author":"Gizzo","year":"2014","journal-title":"Gynecological Endocrinology"},{"issue":"3","key":"10.1002\/14651858.CD006919.pub5-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0015-0282(16)56947-7","article-title":"Should gonadotropin-releasing hormone down-regulation therapy be routine in in vitro fertilization?","volume":"62","author":"Harrison","year":"1994","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD006919.pub5-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.fertnstert.2012.05.024","article-title":"Premature progesterone rise negatively correlated with live birth rate in IVF cycles with GnRH agonist: an analysis of 2,566 cycles","volume":"98","author":"Huang","year":"2012","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD006919.pub5-BIB0075|cit75","unstructured":"Comparison of long protocol and agonist-antagonist protocol in the infertile normal responder patients undergoing ICSI cycles en.irct.ir\/trial\/22056"},{"issue":"2","key":"10.1002\/14651858.CD006919.pub5-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0015-0282(16)58452-0","article-title":"A novel method of ovarian stimulation for in vitro fertilization: bromocriptine-rebound method","volume":"66","author":"Jinno","year":"1996","journal-title":"Fertility and Sterility"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD006919.pub5-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"S235","DOI":"10.1016\/j.fertnstert.2009.07.1579","article-title":"Diminished but significant mid-cycle LH surge can be induced in the long protocol of GNRH agonist and HMG regimen, resulting in a great increase in the rate of ongoing pregnancy","volume":"92","author":"Jinno","year":"2009","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD006919.pub5-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/09513590500282125","article-title":"A preliminary study on reduced dose (33 or 25 g) gonadotropin-releasing hormone agonist long protocol for multi follicular ovaria stimulation in patients with high basal serum follicular-stimulating hormone levels undergoing in vitro fertilization-embryo transfer","volume":"21","author":"Ku","year":"2005","journal-title":"Gynecological Endocrinology"},{"issue":"5","key":"10.1002\/14651858.CD006919.pub5-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S0015-0282(16)53942-9","article-title":"Randomized, prospective trial of leuprolide acetate and conventional superovulation in first cycle of in vitro fertilization and gamete intrafallopian transfer","volume":"54","author":"Kubik","year":"1990","journal-title":"Fertility and Sterility"},{"issue":"11","key":"10.1002\/14651858.CD006919.pub5-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"867","DOI":"10.3109\/09513590.2010.540602","article-title":"The dynamics of endometrial growth and the triple layer appearance in three different controlled ovarian hyperstimulation protocols and their influence on IVF outcomes","volume":"27","author":"Ku\u0107","year":"2011","journal-title":"Gynecological Endocrinology"},{"issue":"1","key":"10.1002\/14651858.CD006919.pub5-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"14","DOI":"10.4103\/0974-1208.97785","article-title":"Clinical outcome of one-third-dose depot triptorelin is the same as half-dose depot triptorelin in the long protocol of controlled ovarian stimulation","volume":"5","author":"Li","year":"2012","journal-title":"Journal of Human Reproductive Sciences"},{"issue":"3","key":"10.1002\/14651858.CD006919.pub5-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1007\/s12020-012-9706-z","article-title":"Comparison of follicular fluid amphiregulin and EGF concentrations in patients undergoing IVF with different stimulation protocols","volume":"42","author":"Liu","year":"2012","journal-title":"Endocrine"},{"issue":"2","key":"10.1002\/14651858.CD006919.pub5-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1080\/09513590310001651830","article-title":"Relationship between gonadotropin releasing hormone agonist dosage and in vitro fertilization outcome","volume":"18","author":"Lorusso","year":"2004","journal-title":"Gynecological Endocrinology"},{"issue":"2","key":"10.1002\/14651858.CD006919.pub5-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0301-2115(98)00125-0","article-title":"The effect of the duration of GnRH-agonist down regulation before ovarian stimulation on the biological and clinical outcome after intracytoplasmic sperm injection","volume":"80","author":"Loutradis","year":"1998","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"key":"10.1002\/14651858.CD006919.pub5-BIB0085|cit85","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1155\/2015\/628056","article-title":"Estradiol valerate pretreatment in short protocol GnRH-agonist cycles versus combined pretreatment with oral contraceptive pills in long protocol GnRH-agonist cycles: a randomised controlled trial","volume":"2015","author":"Lukaszuk","journal-title":"BioMed Research International"},{"issue":"10","key":"10.1002\/14651858.CD006919.pub5-BIB0086|cit86","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1177\/1933719118756753","article-title":"Effect of prolonged GnRH agonist downregulation on ICSI outcome in patients with endometriomas of less than 5 cm: a randomized controlled trial","volume":"25","author":"Maged","year":"2018","journal-title":"Reproductive Sciences (Thousand Oaks, Calif.)"},{"issue":"2","key":"10.1002\/14651858.CD006919.pub5-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/oxfordjournals.humrep.a138030","article-title":"Comparative trial between an ultra-short and long protocol of luteinizing hormone-releasing hormone agonist for ovarian stimulation in in-vitro fertilization","volume":"8","author":"Marcus","year":"1993","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"6","key":"10.1002\/14651858.CD006919.pub5-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S0015-0282(16)54368-4","article-title":"Prospective randomized study of human menotropin versus a follicular and a luteal phase gonadotropin-releasing hormone analog-human menotropin stimulation protocols for in vitro fertilization","volume":"55","author":"Maroulis","year":"1991","journal-title":"Fertility and Sterility"},{"issue":"4","key":"10.1002\/14651858.CD006919.pub5-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1479-828X.1989.tb01782.x","article-title":"Combined treatment with gonadotrophin releasing hormone agonist and gonadotrophins in poor responders to hyperstimulation for in vitro fertilization (IVF): clinical and endocrine results","volume":"29","author":"McKenna","year":"1989","journal-title":"Australian and New Zealand Journal of Obstetrics and Gynaecology"},{"issue":"5","key":"10.1002\/14651858.CD006919.pub5-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/humrep\/der048","article-title":"Timing oocyte collection in GnRH agonists down-regulated IVF and ICSI cycles: a randomized clinical trial","volume":"26","author":"Mochtar","year":"2011","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD006919.pub5-BIB0091|cit91","unstructured":"Effect of the duration of GnRH-analogue downregulation on pregnancy rates in IVF clinicaltrials.gov\/ct2\/show\/NCT00436319"},{"key":"10.1002\/14651858.CD006919.pub5-BIB0092|cit92","unstructured":"Comparative study between minidose long protocol and microdose flare protocol in controlled ovarian hyperstimulation for poor responders in ICSI cycles clinicaltrials.gov\/ct2\/show\/NCT02342197"},{"key":"10.1002\/14651858.CD006919.pub5-BIB0093|cit93","unstructured":"Cumulative pregnancy rate with lower and higher gonadotropin dose during IVF among poor responders clinicaltrials.gov\/study\/NCT05103228"},{"issue":"5","key":"10.1002\/14651858.CD006919.pub5-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1093\/humrep\/13.5.1148","article-title":"The use of long- and short-acting forms of gonadotrophin-releasing hormone analogues in women undergoing oocyte donation","volume":"13","author":"Neuspiller","year":"1998","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"2","key":"10.1002\/14651858.CD006919.pub5-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/oxfordjournals.humrep.a137307","article-title":"Differential effects of gonadotrophin-releasing hormone agonists administered as desensitizing or flare protocols on hormonal function in the luteal phase of hyperstimulated cycles","volume":"6","author":"Norman","year":"1991","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"1","key":"10.1002\/14651858.CD006919.pub5-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0015-0282(16)54421-5","article-title":"The Lupron screening test: tailoring the use of leuprolide acetate in ovarian stimulation for in vitro fertilization","volume":"56","author":"Padilla","year":"1991","journal-title":"Fertility and Sterility"},{"issue":"4","key":"10.1002\/14651858.CD006919.pub5-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0015-0282(16)56650-3","article-title":"Prospective study of a modified gonadotropin-releasing hormone agonist long protocol in an in vitro fertilization program","volume":"61","author":"Pantos","year":"1994","journal-title":"Fertility and Sterility"},{"issue":"11","key":"10.1002\/14651858.CD006919.pub5-BIB0098|cit98","doi-asserted-by":"publisher","first-page":"885","DOI":"10.3109\/09513590.2015.1065481","article-title":"Corifollitropin alfa followed by hpHMG in GnRH agonist protocols. Two prospective feasibility studies in poor ovarian responders","volume":"31","author":"Polyzos","year":"2015","journal-title":"Gynecological Endocrinology"},{"issue":"2","key":"10.1002\/14651858.CD006919.pub5-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/BF01130730","article-title":"The duration of pituitary suppression by means of intranasal gonadotropin hormone-releasing hormone analogue administration does not influence the ovarian response to gonadotropin stimulation and success rate in a gamete intrafallopian transfer (GIFT) program","volume":"6","author":"Remorgida","year":"1989","journal-title":"Journal of In Vitro Fertilization and Embryo Transfer"},{"issue":"3","key":"10.1002\/14651858.CD006919.pub5-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.mefs.2015.12.002","article-title":"Short, semi-short or long GnRH agonist treatment regimens in women ICSI candidate: which is proper in preventing premature LH surge?","volume":"21","author":"Rezaeian","year":"2016","journal-title":"Middle East Fertility Society Journal"},{"issue":"3","key":"10.1002\/14651858.CD006919.pub5-BIB0101|cit101","doi-asserted-by":"publisher","first-page":"76","DOI":"10.5935\/1518-0557.20140011","article-title":"Pituitary suppression with a GnRHa short protocol in an alternate day schedule associated with rhCG microdoses","volume":"18","author":"Rodrigues","year":"2014","journal-title":"JBRA Assisted Reproduction"},{"issue":"6","key":"10.1002\/14651858.CD006919.pub5-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/S0015-0282(16)55563-0","article-title":"Ultrashort gonadotropin-releasing hormone agonist (GnRH-a) protocol in comparison with the long-acting GnRH-a protocol and menotropin alone","volume":"58","author":"Ron-El","year":"1992","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD006919.pub5-BIB0103|cit103","first-page":"ii302","article-title":"Hormonal responses and clinical outcome are the same with three doses of gonadotropin-releasing hormone agonist used in short stimulation protocol","volume":"27 Suppl 2","author":"Sarhan","year":"2012","journal-title":"Human Reproduction"},{"issue":"6","key":"10.1002\/14651858.CD006919.pub5-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0015-0282(16)60733-1","article-title":"Adjuvant leuprolide in normal, abnormal, and poor responders to controlled ovarian hyperstimulation for in vitro fertilization\/gamete intrafallopian transfer","volume":"51","author":"Sathanandan","year":"1989","journal-title":"Fertility and Sterility"},{"issue":"8","key":"10.1002\/14651858.CD006919.pub5-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1093\/oxfordjournals.humrep.a137800","article-title":"The effect of gonadotrophin-releasing hormone (GnRH) agonist in the follicular phase on in-vitro fertilization outcome in normo-ovulatory women","volume":"7","author":"Smitz","year":"1992","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"9","key":"10.1002\/14651858.CD006919.pub5-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1093\/oxfordjournals.humrep.a137831","article-title":"Pituitary gonadotrophin secretory capacity during the luteal phase in superovulation using GnRH-agonists and HMG in a desensitization or flare-up protocol","volume":"7","author":"Smitz","year":"1992","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"Suppl","key":"10.1002\/14651858.CD006919.pub5-BIB0107|cit107","first-page":"i261","article-title":"A comparison of changes in mental distress in women undergoing short versus long in vitro fertilization protocol: a clinical prospective randomized trial","volume":"28","author":"Stenbaek","year":"2013","journal-title":"Human Reproduction"},{"issue":"1","key":"10.1002\/14651858.CD006919.pub5-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF02068868","article-title":"A controlled ovarian hyperstimulation regimen involving intermittent gonadotropin administration with a \"short\" protocol of gonadotropin releasing hormone agonist for in vitro fertilization","volume":"13","author":"Suganuma","year":"1996","journal-title":"Journal of Assisted Reproduction and Genetics"},{"issue":"3","key":"10.1002\/14651858.CD006919.pub5-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"e223","DOI":"10.1016\/j.fertnstert.2014.07.756","article-title":"Selection of an optimal controlled ovarian hyperstimulation method in relation to the number of antral follicles in patients less than 40 years old","volume":"102","author":"Tanaka","year":"2014","journal-title":"Fertility and Sterility"},{"issue":"6","key":"10.1002\/14651858.CD006919.pub5-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/oxfordjournals.humrep.a138146","article-title":"Ovarian stimulation with buserelin\/HMG\/HCG: prospective randomized study of short versus long protocol","volume":"8","author":"Tarlatzis","year":"1993","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"2","key":"10.1002\/14651858.CD006919.pub5-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF02215993","article-title":"Evaluation of two gonadotropin-releasing hormone (GnRH) analogues (leuprolide and buserelin) in short and long protocols for assisted reproduction techniques","volume":"11","author":"Tarlatzis","year":"1994","journal-title":"Journal of Assisted Reproduction and Genetics"},{"issue":"6","key":"10.1002\/14651858.CD006919.pub5-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"945","DOI":"10.5114\/aoms.2010.19306","article-title":"Half-dose, long-acting gonadotropin-releasing hormone agonist (Diphereline) is comparable with daily injections of short-acting gonadotropin-releasing hormone agonist (Suprefact) in IVF\/ICSI cycles","volume":"6","author":"Tehraninejad","year":"2010","journal-title":"Archives of Medical Science"},{"issue":"1","key":"10.1002\/14651858.CD006919.pub5-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"49","DOI":"10.15296\/ijwhr.2021.09","article-title":"Comparison of assisted reproductive technology cycle outcomes among daily buserelin, daily, and every other day triptorelin in infertile patients referring to Imam Khomeini Hospital complex: a randomized controlled trial","volume":"9","author":"Tehraninejad","year":"2021","journal-title":"International Journal of Women's Health and Reproduction Sciences"},{"issue":"3","key":"10.1002\/14651858.CD006919.pub5-BIB0114|cit114","doi-asserted-by":"publisher","first-page":"171","DOI":"10.4103\/npmj.npmj_65_20","article-title":"Comparison of clinical efficacy of long- versus short-acting gonadotrophin-releasing hormone agonists for pituitary down regulation in in vitro fertilisation cycles","volume":"27","author":"Umemmuo","year":"2020","journal-title":"Nigerian Postgraduate Medical Journal"},{"issue":"6","key":"10.1002\/14651858.CD006919.pub5-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/BF01130591","article-title":"Comparison of ovarian stimulation regimens for in vitro fertilization (IVE) with and without a gonadotropin-releasing hormone (GnRH) agonist: results of a randomized study","volume":"7","author":"Van de-Helder","year":"1990","journal-title":"Journal of In Vitro Fertilization and Embryo Transfer"},{"issue":"5","key":"10.1002\/14651858.CD006919.pub5-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.rbmo.2012.02.003","article-title":"Effect of HCG-day serum progesterone and oestradiol concentrations on pregnancy outcomes in GnRH agonist cycles","volume":"24","author":"Wu","year":"2012","journal-title":"Reproductive Biomedicine Online"},{"issue":"6","key":"10.1002\/14651858.CD006919.pub5-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1093\/humrep\/deaa086","article-title":"The depot GnRH agonist protocol improves the live birth rate per fresh embryo transfer cycle, but not the cumulative live birth rate in normal responders: a randomized controlled trial and molecular mechanism study","volume":"35","author":"Xu","year":"2020","journal-title":"Human Reproduction"},{"issue":"11","key":"10.1002\/14651858.CD006919.pub5-BIB0118|cit118","first-page":"1081","article-title":"The use of a long-acting gonadotropin-releasing hormone analog (D-Trp-6-LHRH) for improvement of ovarian stimulation in assisted conception programs","volume":"90","author":"Yang","year":"1991","journal-title":"Journal of the Formosan Medical Association"},{"key":"10.1002\/14651858.CD006919.pub5-BIB0119|cit119","doi-asserted-by":"publisher","first-page":"e6837","DOI":"10.7717\/peerj.6837.","article-title":"Prolonged pituitary down-regulation with full-dose of gonadotropin-releasing hormone agonist in different menstrual cycles: a retrospective cohort study","volume":"7","author":"Ying","year":"2019","journal-title":"PeerJ"},{"key":"10.1002\/14651858.CD006919.pub5-BIB0120|cit120","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1093\/humrep\/deab130.643","article-title":"Effect of a reduced dose of long-acting gonadotropin releasing hormone (GnRH) agonist versus short-acting GnRH agonist on pregnancy outcome in patients undergoing ICSI\/ET cycles","volume":"36","author":"Kabodmehri","year":"2021","journal-title":"Oxford University Press"},{"key":"10.1002\/14651858.CD006919.pub5-BIB0121|cit121","unstructured":"Miniflare versus long protocol in poor responders https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02681536"},{"key":"10.1002\/14651858.CD006919.pub5-BIB0122|cit122","unstructured":"Low dose GnRHa early luteal phase down regulation versus GnRHa ultra-short protocol for poor ovarian response https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02940535"},{"key":"10.1002\/14651858.CD006919.pub5-BIB0123|cit123","unstructured":"Effect of long, short, and ultrashort GnRH agonist treatment protocols in intracytoplasmic sperm injection candidates on ovarian reserve clinicaltrials.gov\/study\/NCT05567731"},{"issue":"6","key":"10.1002\/14651858.CD006919.pub5-BIB0124|cit124","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.fertnstert.2016.02.005","article-title":"A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept","volume":"105","author":"Alviggi","year":"2016","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD006919.pub5-BIB0125|cit125","first-page":"245","article-title":"GnRHagonists and in vitro fertilization","volume":"43 Suppl","author":"Barlow","year":"1998","journal-title":"Journal of Reproductive Medicine"},{"issue":"12","key":"10.1002\/14651858.CD006919.pub5-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1093\/oxfordjournals.humrep.a137976","article-title":"Luteal function following ovulation induction in polycystic ovary syndrome patients using exogenous gonadotrophins in combination with a gonadotrophin-releasing hormone agonist","volume":"8","author":"Donderwinkel","year":"1993","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"1","key":"10.1002\/14651858.CD006919.pub5-BIB0127|cit127","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.fertnstert.2020.11.013","article-title":"Standardizing definitions and reporting guidelines for the infertility core outcome set: an international consensus development study","volume":"115","author":"Duffy","year":"2021","journal-title":"Fertility and Sterility"},{"issue":"8","key":"10.1002\/14651858.CD006919.pub5-BIB0128|cit128","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010537.pub5","article-title":"Assisted reproductive technology: an overview of Cochrane Reviews","author":"Farquhar","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006919.pub5-BIB0129|cit129","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1093\/humrep\/der092","article-title":"ESHRE consensus on the definition of \u201cpoor response\u201d to ovarian stimulation for in vitro fertilization: the Bologna criteria","volume":"26","author":"Ferraretti","year":"2011","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD006919.pub5-BIB0130|cit130","doi-asserted-by":"publisher","first-page":"f650","DOI":"10.1136\/bmj.f650","article-title":"Fertility (update): summary of NICE guidance","volume":"346","author":"Fields","year":"2013","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD006919.pub5-BIB0131|cit131","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012586","article-title":"Controlled ovarian stimulation protocols for assisted reproduction: a network meta-analysis","author":"Gallos","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD006919.pub5-BIB0132|cit132","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013240","article-title":"Long-term GnRH agonist therapy before in vitro fertilisation (IVF) for improving fertility outcomes in women with endometriosis","author":"Georgiou","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD006919.pub5-BIB0133|cit133","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime) 2024"},{"key":"10.1002\/14651858.CD006919.pub5-BIB0134|cit134","volume-title":"Current Practices and Controversies in Assisted Reproduction: Report of a WHO Meeting on \"Medical, Ethical and Social Aspects of Assisted Reproduction\"","author":"Griffin","year":"2002"},{"key":"10.1002\/14651858.CD006919.pub5-BIB0135|cit135","unstructured":"Higgins JP Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1\/"},{"issue":"5","key":"10.1002\/14651858.CD006919.pub5-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S0015-0282(16)55430-2","article-title":"The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials","volume":"58","author":"Hughes","year":"1992","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD006919.pub5-BIB0137|cit137","unstructured":"The use of GnRH agonist in IVF protocols: survey results ivf-worldwide.com\/survey\/the-use-of-gnrh-agonist-in-ivf-protocols\/results-the-use-of-gnrh-agonist-in-ivf-protocols.html"},{"key":"10.1002\/14651858.CD006919.pub5-BIB0138|cit138","first-page":"132","article-title":"The influence, development and management of functional ovarian cysts during IVF cycles","volume":"1","author":"Jenkins","year":"1996","journal-title":"Journal of the British Fertility Society"},{"issue":"3","key":"10.1002\/14651858.CD006919.pub5-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3109\/09513590.2010.526667","article-title":"Gonadotrophin-releasing hormone-antagonists vs long agonist in in-vitro fertilization patients with polycystic ovary syndrome: a meta-analysis","volume":"27","author":"Mancini","year":"2011","journal-title":"Gynecological Endocrinology"},{"issue":"4","key":"10.1002\/14651858.CD006919.pub5-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1210\/jcem-58-4-755","article-title":"Stimulation of LH fragments with reduced bioactivity following GnRH agonist administration in women","volume":"58","author":"Meldrum","year":"1984","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"2","key":"10.1002\/14651858.CD006919.pub5-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3109\/09513590.2012.730569","article-title":"Minimal stimulation protocol using letrozole versus microdose flare up GnRH agonist protocol in women with poor ovarian response undergoing ICSI","volume":"29","author":"Mohsen","year":"2013","journal-title":"Gynecological Endocrinology"},{"issue":"8724","key":"10.1002\/14651858.CD006919.pub5-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/0140-6736(90)92765-A","article-title":"Hypersecretion of luteinising hormone, infertility, and miscarriage","volume":"336","author":"Regan","year":"1990","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD006919.pub5-BIB0143|cit143","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2024"},{"issue":"20","key":"10.1002\/14651858.CD006919.pub5-BIB0144|cit144","first-page":"4354","article-title":"Short gonadotropin-releasing hormone agonist versus flexible antagonist versus clomiphene citrate regimens in poor responders undergoing in vitro fertilization: a randomized controlled trial","volume":"20","author":"Schimberni","year":"2016","journal-title":"European Review for Medical and Pharmacological Sciences"},{"issue":"7129","key":"10.1002\/14651858.CD006919.pub5-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/bmj.316.7129.469","article-title":"Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity","volume":"316","author":"Stuck","year":"1998","journal-title":"BMJ"},{"issue":"3","key":"10.1002\/14651858.CD006919.pub5-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0015-0282(16)57443-3","article-title":"Profound luteinizing hormone suppression after stopping the gonadotropin-releasing hormone-agonist leuprolide acetate","volume":"63","author":"Sungurtekin","year":"1995","journal-title":"Fertility and Sterility"},{"issue":"7","key":"10.1002\/14651858.CD006919.pub5-BIB0147|cit147","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009154","article-title":"Luteal phase support for assisted reproduction cycles","author":"Van der Linden","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD006919.pub5-BIB0148|cit148","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13012-017-0635-3","article-title":"Psychometric assessment of three newly developed implementation outcome measures","volume":"12","author":"Weiner","year":"2017","journal-title":"Implementation Science"},{"issue":"5","key":"10.1002\/14651858.CD006919.pub5-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/humrep\/15.5.1003","article-title":"Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction","volume":"15","author":"Westergaard","year":"2000","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"9","key":"10.1002\/14651858.CD006919.pub5-BIB0150|cit150","doi-asserted-by":"publisher","first-page":"1786\u20131801","DOI":"10.1093\/humrep\/dex234","article-title":"The International Glossary on Infertility and Fertility Care, 2017","volume":"32","author":"Zegers-Hochschild","year":"2017","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"2","key":"10.1002\/14651858.CD006919.pub5-BIB0151|cit151","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001299","article-title":"Gonadotropin releasing hormone agonist protocols for pituitary desensitization in in vitro fertilization and gamete intrafallopian transfer cycles","author":"Daya","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD006919.pub5-BIB0152|cit152","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006919.pub3","article-title":"Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction","author":"Maheshwari","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD006919.pub5-BIB0153|cit153","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006919.pub4","article-title":"Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction","author":"Siristatidis","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T03:03:58Z","timestamp":1784775838000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD006919.pub5"}},"subtitle":[],"editor":[{"name":"Cochrane Gynaecology and Fertility Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,1,9]]},"references-count":153,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006919.pub5","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,9]]}}}